Pacific Hospital Supply Co., Ltd (TPEX:4126)
Taiwan · Delayed Price · Currency is TWD 89.80
+0.80 (0.90%)
Aug 1, 2025, 1:30 PM CST
Intra-Cellular Therapies Market Cap
Pacific Hospital Supply has a market cap or net worth of 6.52 billion as of August 1, 2025. Its market cap has increased by 1.35% in one year.
Market Cap
6.52B
Enterprise Value
5.77B
Revenue
2.39B
Ranking
n/a
PE Ratio
13.88
Stock Price
$89.80
Market Cap Chart
Since November 3, 2004, Pacific Hospital Supply's market cap has increased from 438.30M to 6.52B, an increase of 1,387.44%. That is a compound annual growth rate of 13.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 6.52B | -7.99% |
| Dec 31, 2024 | 7.09B | 12.96% |
| Dec 29, 2023 | 6.27B | 14.44% |
| Dec 30, 2022 | 5.48B | 0.53% |
| Dec 30, 2021 | 5.45B | 7.29% |
| Dec 31, 2020 | 5.08B | 3.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 187.67B |
| PharmaEssentia | 165.30B |
| Bora Pharmaceuticals Co., LTD. | 85.03B |
| Lotus Pharmaceutical | 57.06B |
| Oneness Biotech | 30.42B |
| Polaris Group | 27.62B |
| Center Laboratories | 26.57B |
| Pegavision | 24.02B |